Decision: Favourable

Decisions Table

Study Title:

A multicenter, randomized, double-blind, parallel group, placebo-controlled study to assess safety, tolerability, pharmacokinetic and pharmacodynamics of BI 764198

  • NREC Code:

    22-NREC-CT-096

  • Decision:

    Favourable

  • Meeting Date:

    25/05/2022

  • Study Type:

    CT application

  • Principal Investigator:

    Professor Peter J Conlon

  • PI Institution:

    Beaumont Hospital

  • Sponsor:

    Boehringer Ingelheim

Scroll to Top